Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4007 Pharmacy

Not Yet Opened 05-18 16:00:00 EDT

867.47

-0.07

-0.01%

High871.54	Low862.48	Vol354.62M
Open867.54	D1 Closing867.54	Amplitude1.04%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O11.41B	T/O Rate--	Tradable Shares0.00
P/B5.212564	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4007","market":"US","secType":"PLATE","nameCN":"Pharmacy","latestPrice":867.46796,"timestamp":1779134399999,"preClose":867.5379,"halted":0,"volume":354620402,"delay":0,"changeRate":-0.000081,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-0.069946,"latestTime":"05-18 16:00:00 EDT","open":867.53796,"high":871.53613,"low":862.4759,"amount":11406803112.201984,"amplitude":0.010444,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779177600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.212564,"peRate":26.387708,"turnoverRate":0.008066,"increases":52,"decrements":130,"flats":6,"marketCap":3396848326018,"floatMarketCap":3244766041947.0625},"requestUrl":"/m/hq/s/BK4007/tweets","defaultTab":"tweets","newsList":[{"id":"2636838924","title":"Purple Biotech Ltd reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2636838924","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636838924?lang=en_us&edition=fundamental","pubTime":"2026-05-19 15:02","pubTimestamp":1779174176,"startTime":"0","endTime":"0","summary":"Purple Biotech Ltd reports results for the quarter ended March 31 - Earnings SummaryPurple Biotech Ltd PPBT.OQ reported quarterly adjusted earnings of 9 cents per share for the quarter ended March 31.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nL8N41W0DC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PPBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636803388","title":"Tern plc raises £222,000 in new IoT-focused share placing","url":"https://stock-news.laohu8.com/highlight/detail?id=2636803388","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636803388?lang=en_us&edition=fundamental","pubTime":"2026-05-19 14:19","pubTimestamp":1779171548,"startTime":"0","endTime":"0","summary":"Tern plc ( ($GB:TERN) ) has provided an announcement. Tern plc, an AIM-quoted investor in Internet of Things technology businesses, has completed a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tern-plc-raises-222000-in-new-iot-focused-share-placing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tern-plc-raises-222000-in-new-iot-focused-share-placing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TERN","LU0109394709.USD","LU0889565916.HKD","BK4007","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636880821","title":"Coiled Therapeutics Lists on U.S. OTCQB to Broaden Investor Base","url":"https://stock-news.laohu8.com/highlight/detail?id=2636880821","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636880821?lang=en_us&edition=fundamental","pubTime":"2026-05-19 14:09","pubTimestamp":1779170955,"startTime":"0","endTime":"0","summary":"An update from Roquefort Investments PLC ( ($GB:COIL) ) is now available. Coiled Therapeutics plc, a clinical-stage oncology company listed on AIM,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/coiled-therapeutics-lists-on-u-s-otcqb-to-broaden-investor-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/coiled-therapeutics-lists-on-u-s-otcqb-to-broaden-investor-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636884530","title":"OTC Markets approves Reviva Pharmaceuticals for trading on OTCQB Venture Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2636884530","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636884530?lang=en_us&edition=fundamental","pubTime":"2026-05-19 12:36","pubTimestamp":1779165380,"startTime":"0","endTime":"0","summary":"OTC Markets Group said three companies were cleared to begin trading on its OTCQB Venture Market on May 18.The new OTCQB names include Reviva Pharmaceuticals, Uraniumx Discovery, zSpace.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OTC Markets Group Inc. published the original content used to generate this news brief on May 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDLbdFSct:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZSPC","OTCM","BK4112","BK4007","BK4204","RVPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636881349","title":"Alterity Therapeutics Says Data Presentations Support Phase Three Development for Multiple System Atrophy Treatment Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2636881349","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636881349?lang=en_us&edition=fundamental","pubTime":"2026-05-19 11:45","pubTimestamp":1779162331,"startTime":"0","endTime":"0","summary":"Alterity Therapeutics  said data it presented at three medical conferences support the advancement of its ATH434 treatment candidate for multiple system atrophy into phase three clinical development, according to a Tuesday filing with the Australian bourse.One presentation highlighted new research that shows Alterity's magnetic resonance imaging approach can detect the neurodegenerative disease, which is characterized by failure of the autonomic nervous system and impaired movement, in its earliest stages.Meanwhile, a new analysis of the company's phase two trial showed evidence that supports ATH434's impact on slowing the progression of multiple system atrophy.\"These data continue to strengthen the evidence that ATH434 has the potential to be the first disease-modifying treatment for [multiple system atrophy], a rare and devastating disease with no approved therapy,\" said Alterity Therapeutics CEO David Stamler.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","LENZ","BK4139","BK4539","ATH.AU","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636788115","title":"Should Perrigo’s (PRGO) Steep Goodwill Impairment and Wider Losses Prompt a Rethink From Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2636788115","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636788115?lang=en_us&edition=fundamental","pubTime":"2026-05-19 11:29","pubTimestamp":1779161344,"startTime":"0","endTime":"0","summary":"Perrigo Company plc recently reported first-quarter 2026 results showing sales of US$969.2 million, a very large net loss of US$398.6 million, and goodwill impairment charges of US$330.8 million, compared with much smaller losses and impairments a year earlier.\nDespite this sharp deterioration in reported earnings and higher impairment charges, Perrigo reaffirmed its 2026 guidance calling for total net sales to decline between 5.5% and 1.5%, underscoring continued operational...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-prgo/perrigo/news/should-perrigos-prgo-steep-goodwill-impairment-and-wider-los","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-prgo/perrigo/news/should-perrigos-prgo-steep-goodwill-impairment-and-wider-los","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","ISBC","BK4007","IE00BFMHRM44.USD","PRGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151449608","title":"Fujian Aims for Over 300 Billion Yuan in Photonics Cluster Revenue by 2030, Accelerates R&D on High-Speed Optical Modules","url":"https://stock-news.laohu8.com/highlight/detail?id=1151449608","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151449608?lang=en_us&edition=fundamental","pubTime":"2026-05-19 10:32","pubTimestamp":1779157953,"startTime":"0","endTime":"0","summary":"The \"Fujian Province '16th Five-Year Plan' High-Quality Development Action Plan for the Photonics Industry Cluster (Draft for Comments)\" has recently been released for public consultation. It...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065732104.USD","OCS","NPO","BK4007","BK4161","LU1559883803.SGD","IE0034390439.USD","IE00B19Z6F94.USD","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636288636","title":"Top Executive Makes Bold Move With Major Aurora Acquisition Stock Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2636288636","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636288636?lang=en_us&edition=fundamental","pubTime":"2026-05-19 10:14","pubTimestamp":1779156889,"startTime":"0","endTime":"0","summary":"New insider activity at Aurora Acquisition ( ($BETR) ) has taken place on May 18, 2026. Aurora Acquisition’s CEO, Garg Vishal, has demonstrated str...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-bold-move-with-major-aurora-acquisition-stock-purchase-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-bold-move-with-major-aurora-acquisition-stock-purchase-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","ACB","MSOS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636886333","title":"Top Executive’s Sudden Stock Sale Sparks Fresh Buzz Around Aquestive Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2636886333","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636886333?lang=en_us&edition=fundamental","pubTime":"2026-05-19 10:14","pubTimestamp":1779156846,"startTime":"0","endTime":"0","summary":"New insider activity at Aquestive Therapeutics ( ($AQST) ) has taken place on May 18, 2026. President and CEO Daniel Barber of Aquestive Therapeuti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executives-sudden-stock-sale-sparks-fresh-buzz-around-aquestive-therapeutics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executives-sudden-stock-sale-sparks-fresh-buzz-around-aquestive-therapeutics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145380915","title":"SKB BIO Shares Surge Over 5% in Morning Session on Merck's TROP2 ADC Therapy Phase 3 Success","url":"https://stock-news.laohu8.com/highlight/detail?id=1145380915","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145380915?lang=en_us&edition=fundamental","pubTime":"2026-05-19 09:41","pubTimestamp":1779154861,"startTime":"0","endTime":"0","summary":"SKB BIO (06990) rose more than 5% in morning trading. At the time of writing, the stock was up 4.71% to HK$444.2, with a turnover of HK$38.44 million. The move follows an announcement from Merck that...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002232.USD","LU1035773651.USD","IE00BFTCPJ56.SGD","LU2468319806.SGD","SG9999014575.USD","SG9999001176.USD","LU2125154935.USD","BK4231","BK4007","LU1934455194.USD","LU0203345920.USD","SG9999014567.USD","LU1066053197.SGD","LU1093756168.USD","BK4588","BK4516","LU0859254822.USD","IE0009355771.USD","LU0266013472.USD","IE00BSNM7G36.USD","LU0234572021.USD","LU1066051225.USD","LU1923622614.USD","LU1430594728.SGD","SG9999001176.SGD","LU1917777945.USD","LU0130102774.USD","LU0320765646.SGD","SG9999014542.SGD","LU2089984988.USD","LU0965509010.AUD","BK4534","LU2125909247.SGD","LU2125154778.USD","LU2491050071.SGD","LU1699723380.USD","LU2023250504.SGD","IE00BBT3K403.USD","LU1291159041.SGD","LU0196878994.USD","LU0058720904.USD","LU0432979614.USD","LU1069347547.HKD","SG9999015341.SGD","SG9999002224.SGD","SGXZ57979304.SGD","LU0203347892.USD","IE00BLSP4452.SGD","LU1934455863.HKD","IE00B4R5TH58.HKD","LU0965509101.SGD","IE000M9KFDE8.USD","LU2106854487.HKD","LU0868494617.USD","LU1929549753.HKD","LU2112291526.USD","LU1037948541.HKD","LU0868494708.USD","LU2361044865.SGD","LU2491050154.USD","LU1989772840.SGD","LU1061106388.HKD","LU0289739699.SGD","LU2360032135.SGD","LU1162221912.USD","LU0985320562.USD","LU2023250843.SGD","BK1161","LU0648001328.SGD","LU0070302665.USD","BK4550","BK4080","LU1941712264.USD","LU1116320737.USD","LU1057294990.SGD","LU1023059063.AUD","LU1983299246.USD","LU2461242641.AUD","LU1974910355.USD","LU1093756325.SGD","LU0006306889.USD","LU1989772923.USD","LU0320765489.SGD","SG9999013999.USD","LU0265550946.USD","IE00BN8TJ469.HKD","LU0130517989.USD","LU0208291251.USD","SG9999001440.SGD","LU0122379950.USD","LU0965509283.SGD","IE00BJT1NW94.SGD","SG9999014559.SGD","LU1585245621.USD","LU0265550359.USD","LU1989771016.USD","LU2361045086.USD","LU1066051811.HKD","LU1066051498.USD","IE00BJJMRZ35.SGD","LU2357627491.SGD","IE00BLSP4239.USD","LU0980610538.SGD","LU2125909593.SGD","LU2361044949.HKD","BK4585","LU2491049909.HKD","LU1201861249.SGD","LU2324357040.USD","LU0106261372.USD","LU2433249047.HKD","IE0002141913.USD","LU1116320901.HKD","LU0942090050.USD","SG9999015358.SGD","06990","LU0211331839.USD","LU0477156953.USD","LU1571399168.USD","LU1037948897.HKD","LU0861579265.USD","BK4559","IE00B2B36J28.USD","LU1941712348.USD","BK4533","IE00B1BXHZ80.USD","LU0098860793.USD","LU0238689110.USD","LU1934455277.USD","LU0965508806.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636000834","title":"Glenbrook Capital Management acquires SenesTech shares worth $55,849.09","url":"https://stock-news.laohu8.com/highlight/detail?id=2636000834","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636000834?lang=en_us&edition=fundamental","pubTime":"2026-05-19 08:11","pubTimestamp":1779149510,"startTime":"0","endTime":"0","summary":"Glenbrook Capital Management, a more-than-10% owner of SenesTech, reported open-market purchases totaling 32,120 common shares.The buys were executed at prices ranging from USD 1.59 to USD 1.72 per share.Indirect beneficial ownership rose to 925,755 shares following the transactions.The filing was signed by John David Kessler, director.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SenesTech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL2kzX03:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNES","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636071300","title":"Amplia Therapeutics to Start Phase 2B Study of Pancreatic Cancer Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2636071300","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636071300?lang=en_us&edition=fundamental","pubTime":"2026-05-19 07:56","pubTimestamp":1779148606,"startTime":"0","endTime":"0","summary":"Amplia Therapeutics  is initiating a phase 2b study of its narmafotinib drug candidate in combination with chemotherapies gemcitabine and Abraxane in newly diagnosed advanced pancreatic cancer patients to explore a new dosing regimen, according to a Tuesday Australian bourse filing.Each dosing group will have six patients, which will be combined with gemcitabine and Abraxane given on their conventional schedule, the filing said. The study will assess safety and tolerability, pharmacokinetics, and efficacy. Exploratory endpoints will include effects on disease biomarkers as well as effects on fibrosis.The study, designed in alignment with US Food and Drug Administration feedback, will enroll patients across three to four sites in Australia starting in the fourth quarter, per the filing. It will form the first stage of a registrational study in this indication.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4139","BK4007","ATX.AU","BK7067","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636007588","title":"Akari Therapeutics Delays Quarterly SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2636007588","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636007588?lang=en_us&edition=fundamental","pubTime":"2026-05-19 07:27","pubTimestamp":1779146834,"startTime":"0","endTime":"0","summary":"Akari Therapeutics ( ($AKTX) ) has released a notification of late filing. Akari Therapeutics, Plc has filed a Form 12b-25 to notify investors that...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/akari-therapeutics-delays-quarterly-sec-filing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/akari-therapeutics-delays-quarterly-sec-filing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636138002","title":"Rapport Therapeutics assumed with a Buy at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2636138002","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636138002?lang=en_us&edition=fundamental","pubTime":"2026-05-19 07:00","pubTimestamp":1779145236,"startTime":"0","endTime":"0","summary":"Truist assumed coverage of Rapport Therapeutics (RAPP) with a Buy rating with a price target of $56, up from $44. The firm’s thesis is largely cons...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-assumed-with-a-buy-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-assumed-with-a-buy-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636300213","title":"Silence Therapeutics Establishes New At-The-Market Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2636300213","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636300213?lang=en_us&edition=fundamental","pubTime":"2026-05-19 06:59","pubTimestamp":1779145169,"startTime":"0","endTime":"0","summary":"Silence Therapeutics ( ($SLN) ) just unveiled an announcement. On May 18, 2026, Silence Therapeutics entered a new Open Market Sale Agreement with ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/silence-therapeutics-establishes-new-at-the-market-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/silence-therapeutics-establishes-new-at-the-market-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636004437","title":"EXPLAINER-What do we know about the Bundibugyo strain of the Ebola virus?","url":"https://stock-news.laohu8.com/highlight/detail?id=2636004437","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636004437?lang=en_us&edition=fundamental","pubTime":"2026-05-19 06:13","pubTimestamp":1779142391,"startTime":"0","endTime":"0","summary":"The current Ebola outbreak - so far limited to the Democratic Republic of the Congo and Uganda - is due to a rare strain of the virus known as Bundibugyo, named after Uganda’s Bundibugyo province where it was first identified during an outbreak in 2007-2008. A second Bundibugyo outbreak occurred in 2012 in the DRC.Bundibugyo kills 30% to 40% of infected people, making it less lethal than the more common Zaire strain, which causes death in up to 90%, according to a global study published in 2024.Bundibugyo is one of the four species of ebolavirus genus that cause life-threatening illness in humans. All Ebola viruses are transmitted through direct contact with the bodily fluids of infected animals or humans or objects contaminated with such fluids.Body fluid transmission is a particular risk for hospital workers. A U.S. doctor working in the DRC has been infected in the current outbreak.  According to the World Health Organization, ebolaviruses initially cause flu-like symptoms including","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nL1N41V0TM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455863.HKD","SG9999001440.SGD","LU1923622614.USD","LU0130517989.USD","SG9999001176.USD","BK4568","LU1037948541.HKD","IE00BN8TJ469.HKD","LU1066053197.SGD","SG9999014567.USD","LU0203345920.USD","LU1941712348.USD","LU0208291251.USD","LU0211331839.USD","LU1929549753.HKD","LU2125909593.SGD","LU0965509010.AUD","LU0058720904.USD","IE0002141913.USD","LU2106854487.HKD","BK4550","IE00BBT3K403.USD","SG9999002224.SGD","LU0965508806.USD","LU2361044949.HKD","LU1989771016.USD","LU0070302665.USD","SG9999013999.USD","LU0861579265.USD","LU1571399168.USD","LU1037948897.HKD","LU0965509283.SGD","LU1585245621.USD","LU0265550359.USD","SG9999001176.SGD","LU0266013472.USD","SG9999015358.SGD","LU1934455194.USD","IE00B2B36J28.USD","LU1983299246.USD","BK4585","LU0098860793.USD","SG9999015341.SGD","LU2023250843.SGD","LU0980610538.SGD","BK4139","LU0320765646.SGD","BK4516","BK4533","IE00BJJMRZ35.SGD","SG9999014542.SGD","LU1093756168.USD","LU0942090050.USD","BK4007","IE00BFTCPJ56.SGD","LU0477156953.USD","LU1057294990.SGD","LU0868494617.USD","LU1699723380.USD","LU2324357040.USD","LU1066051498.USD","LU2360032135.SGD","NNVC","LU2491049909.HKD","SG9999002232.USD","LU2023250504.SGD","LU0648001328.SGD","SG9999014559.SGD","LU2089984988.USD","LU1069347547.HKD","LU0265550946.USD","LU1989772840.SGD","LU0234572021.USD","IE00B4R5TH58.HKD","LU1201861249.SGD","LU1023059063.AUD","LU0965509101.SGD","SG9999014575.USD","LU0289739699.SGD","LU0320765489.SGD","LU1941712264.USD","LU1035773651.USD","LU2112291526.USD","LU2125154778.USD","BK4534","IE00BLSP4452.SGD","LU1061106388.HKD","LU0985320562.USD","LU0130102774.USD","LU1116320737.USD","LU1162221912.USD","LU1066051225.USD","LU1116320901.HKD","BK4559","LU0859254822.USD","LU1917777945.USD","IE00BSNM7G36.USD","LU0122379950.USD","LU1430594728.SGD","IE0009355771.USD","LU1291159041.SGD","IE00BJT1NW94.SGD","IE00B1BXHZ80.USD","LU2125154935.USD","MRK","LU0432979614.USD","LU2491050071.SGD","IE000M9KFDE8.USD","LU0203347892.USD","LU1974910355.USD","IE00BLSP4239.USD","LU2461242641.AUD","LU2468319806.SGD","LU0106261372.USD","LU2125909247.SGD","LU2357627491.SGD","LU1934455277.USD","SGXZ57979304.SGD","LU0868494708.USD","LU2433249047.HKD","LU1989772923.USD","LU1093756325.SGD","BK4588","LU2361045086.USD","LU0238689110.USD","LU0006306889.USD","LU2491050154.USD","LU2361044865.SGD","LU1066051811.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636004993","title":"Innoviva Appoints Josephine Linden to Strengthen Board Oversight","url":"https://stock-news.laohu8.com/highlight/detail?id=2636004993","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636004993?lang=en_us&edition=fundamental","pubTime":"2026-05-19 05:47","pubTimestamp":1779140867,"startTime":"0","endTime":"0","summary":"Innoviva ( ($INVA) ) has shared an update. On May 12, 2026, Innoviva directors Derek Small and Mark DiPaolo resigned from the board to concentrate ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/innoviva-appoints-josephine-linden-to-strengthen-board-oversight?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/innoviva-appoints-josephine-linden-to-strengthen-board-oversight?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INVA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636001764","title":"Novavax Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2636001764","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636001764?lang=en_us&edition=fundamental","pubTime":"2026-05-19 05:27","pubTimestamp":1779139620,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  slid 1.43% to $8.93 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.32% to 49,686.12 and the NASDAQ Composite Index  falling 0.51% to 26,090.73.This was the stock's second consecutive day of losses.Novavax Inc. closed 25.40% short of its 52-week high of $11.97, which the company reached on February 26th.The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson  rose 0.97% to $228.92, Pfizer Inc.  remained unchanged, and Merck & Co. Inc.  rose 1.06% to $112.56.Trading volume  eclipsed its 50-day average volume of 4.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 18, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Stre","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689626769.HKD","LU1732799900.SGD","LU1201861249.SGD","LU2023250330.USD","IE00BZ1G4Q59.USD","LU0648001328.SGD","LU1043141396.HKD","LU2456880835.USD","BK4139","IE000MB6IJN5.SGD","LU0345769128.USD","IE00B3PB1722.GBP","LU0820562030.AUD","LU2213496289.HKD","LU1941712348.USD","LU0882574055.USD","IE000SO60NU8.SGD","IE00B4R5TH58.HKD","LU1121112475.USD","LU2417539215.USD","LU0070217475.USD","LU1244550577.SGD","LU1291159041.SGD","LU2471134952.CNY","IE00BJT1NW94.SGD","IE00B2B36J28.USD","SG9999013999.USD","SG9999001176.SGD","LU0130102774.USD","LU0122379950.USD","LU1023059063.AUD","LU2089984988.USD","LU1674673428.USD","LU0265550359.USD","LU1551013342.USD","LU2602419157.SGD","IE00BDGV0183.EUR","LU0787776722.HKD","LU1221951046.USD","LU1929549753.HKD","LU2361044865.SGD","IE00BLSP4239.USD","LU2023250843.SGD","LU2430703251.USD","LU1941712264.USD","LU0234572021.USD","IE00B3T34201.USD","LU1093756168.USD","LU1778281490.HKD","IE00B1BXHZ80.USD","IE000F7OJYX1.SGD","SG9999001176.USD","LU1032466523.USD","LU0289739699.SGD","LU2505996681.GBP","LU1989772923.USD","IE0001KFT4U8.USD","LU0820561818.USD","LU0058720904.USD","LU1506573853.SGD","LU1066051498.USD","IE0034235303.USD","LU0225284248.USD","LU0203347892.USD","LU1035773651.USD","IE00BFTCPJ56.SGD","LU1732800096.USD","IE0009355771.USD","LU2430703095.HKD","IE00BJJMRZ35.SGD","SG9999014575.USD","LU0795875086.SGD","LU1043141123.HKD","IE00BLSP4452.SGD","LU0965509101.SGD","LU0265550946.USD","LU0980610538.SGD","LU2023250504.SGD","LU2468319806.SGD","LU2471134523.USD","SG9999003800.SGD","SG9999014567.USD","LU1674673691.USD","BK4585","LU1059921491.USD","LU1585245621.USD","LU2236285917.USD","LU0266013472.USD","LU0820561909.HKD","IE00BGHQF631.EUR","LU0943347566.SGD","LU1037948541.HKD","LU0210528500.USD","LU0234570918.USD","LU0345769631.USD","LU0456855351.SGD","LU0985481810.HKD","LU1032955483.USD","LU1496350502.SGD","LU1629891620.HKD","IE00B19Z3B42.SGD","LU0106261372.USD","LU0861579265.USD","LU2129689605.HKD","LU1228905540.USD","LU2491050154.USD","LU2505996509.AUD","NVAX","LU0466842654.USD","LU1066051225.USD","IE00BFXG1179.USD","IE00BVYPNV92.GBP","IE00BBT3K403.USD","BK4516","LU2896262040.SGD","LU2461242641.AUD","LU1244550494.USD","LU1571399168.USD","LU2433249047.HKD","IE0000B7K699.USD","LU0306807586.USD","LU2357627491.SGD","LU1883839398.USD","LU0683600562.USD","LU2125909247.SGD","SG9999015358.SGD","IE0002141913.USD","LU0320765489.SGD","LU1983299246.USD","IE00B7SZLL34.SGD","LU0321505439.SGD","LU1116320737.USD","LU2125154935.USD","LU0345770993.USD","LU1066053197.SGD","LU1934455194.USD","LU2592432038.USD","LU1935042991.SGD","LU2471134879.HKD","LU2750360997.AUD","BK4532","LU0868494617.USD","LU0994945656.USD","BK4581","LU1699723380.USD","LU0053666078.USD","LU0345770308.USD","BK4592","LU0306806265.USD","LU0912757837.SGD","BK4550","LU1069347547.HKD","LU1934455277.USD","SG9999002224.SGD","SG9999014559.SGD","LU0942090050.USD","LU2756315664.SGD","LU1914381329.SGD","LU0792757196.USD","LU1934455863.HKD","LU2491050071.SGD","LU0211331839.USD","LU1196500208.SGD","LU1989771016.USD","LU2756315318.SGD","LU1066051811.HKD","LU1244550221.USD","IE000BZT7R73.USD","LU0795875169.SGD","LU2125909593.SGD","LU2361044949.HKD","IE00BN8TJ469.HKD","LU0859254822.USD","LU2487616109.SGD","BK4559","LU0114720955.EUR","LU0124676726.USD","LU2491049909.HKD","LU0203345920.USD","LU0238689110.USD","LU2129689431.USD","LU0640476718.USD","LU1093756325.SGD","IE00B42XCP33.USD","IE00BVYPNW00.USD","LU0320765646.SGD","IE00BSNM7G36.USD","LU0070302665.USD","LU2471134796.USD","IE00B19Z3581.USD","LU2125154778.USD","LU1261432733.SGD","LU0426412945.USD","LU0964807845.USD","LU0985320562.USD","SG9999015341.SGD","LU1974910355.USD","IE000WAW04H5.SGD","SG9999011175.SGD","LU1057294990.SGD","LU1894683348.USD","IE0002270589.USD","LU0426417589.USD","LU2129689514.USD","SGXZ57979304.SGD","LU0208291251.USD","BK4533","LU1061106388.HKD","LU0432979614.USD","LU0210536198.USD","BK4599","BK4547","LU1037948897.HKD","LU1162221912.USD","LU2133065610.SGD","LU0965508806.USD","LU0321505868.SGD","LU1267930813.SGD","LU0889566641.SGD","LU2403377893.USD","BK4534","LU2347655156.SGD","SG9999001440.SGD","LU1145028129.USD","LU1923622614.USD","BK4588","LU0098860793.USD","LU0225771236.USD","LU0477156953.USD","LU0868494708.USD","LU0170899867.USD","BK4007","LU1221951129.SGD","LU0689472784.USD","LU1280957306.USD","LU2361045086.USD","LU0965509010.AUD","LU0965509283.SGD","LU1989772840.SGD","LU1917777945.USD","BK4504","LU2324357040.USD","LU2360032135.SGD","IE000M9KFDE8.USD","LU1116320901.HKD","SG9999002232.USD","LU2112291526.USD","LU1551013425.SGD","LU1228905037.USD","LU0545562505.USD","SG9999014542.SGD","LU0130517989.USD","BK4568","LU1894683264.USD","LU1718418525.SGD","LU1074936037.SGD","IE00BKVL7J92.USD","LU2106854487.HKD","LU2750360641.GBP","LU2430703178.SGD","LU1430594728.SGD","LU0006306889.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636001145","title":"Akari Therapeutics delays quarterly report filing for March 31, 2026 quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2636001145","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636001145?lang=en_us&edition=fundamental","pubTime":"2026-05-19 05:15","pubTimestamp":1779138956,"startTime":"0","endTime":"0","summary":"Akari Therapeutics filed a late notice for its Form 10-Q for the quarter ended March 31, 2026, citing work tied to a previously announced public offering and related disclosures.The filing is expected within the SEC’s five-calendar-day extension period under Rule 12b-25.The quarterly results are expected to show a significant change from the prior-year period due to a material non-cash impairment charge triggered by a sustained decline in market price and market capitalization versus net asset carrying value.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akari Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Se","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL238vTX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AKTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636001121","title":"Insulet Corp. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2636001121","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636001121?lang=en_us&edition=fundamental","pubTime":"2026-05-19 05:15","pubTimestamp":1779138900,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Insulet Corp.  rose 3.41% to $152.49 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.32% to 49,686.12 and the S&P 500 Index  falling 0.07% to 7,403.05.The stock's rise snapped a three-day losing streak.Insulet Corp. closed 57.03% below its 52-week high of $354.88, which the company achieved on November 20th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Eli Lilly & Co.  fell 1.67% to $988.09, DexCom Inc.  rose 5.61% to $65.09, and Johnson & Johnson  rose 0.97% to $228.92.Trading volume  eclipsed its 50-day average volume of 1.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 18, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1496350502.SGD","LU1923622614.USD","IE00BVYPNV92.GBP","LU0820561909.HKD","LU2357305700.SGD","LU0994945656.USD","LU2756315664.SGD","LU0320765059.SGD","LU1720051017.SGD","LU2237443382.USD","LU1868836757.USD","LU2456880835.USD","BK4551","LU1066051225.USD","LU1061106388.HKD","LU1196500208.SGD","LU1366192091.USD","LU1551013425.SGD","LU1244550577.SGD","IE0005OL40V9.USD","LU0912757837.SGD","LU0985320562.USD","LU0198837287.USD","IE000WAW04H5.SGD","BK4007","IE0034235303.USD","LU1232071149.USD","IE00BFXG1179.USD","LU0728928796.USD","LU0708995401.HKD","LU2089984988.USD","LU0964807845.USD","BK4585","LU0266013472.USD","IE00BN8TJ469.HKD","IE000F7OJYX1.SGD","IE00BJJMRX11.SGD","LU0203201768.USD","LU1261432733.SGD","IE00BLSP4452.SGD","LU1035775433.USD","LU2237443895.HKD","LU1935042991.SGD","LU2756315318.SGD","LU1244550221.USD","LU2430703178.SGD","SG9999014880.SGD","LU0289739699.SGD","LU2095319765.USD","LU0820562030.AUD","SG9999001440.SGD","LU1804176565.USD","LU2471134952.CNY","LU2108987350.USD","SGXZ57979304.SGD","LU1894683264.USD","LU0354030438.USD","LU1032955483.USD","LU1623119135.USD","IE00BJT1NW94.SGD","LU1674673428.USD","LU1066051811.HKD","LU1989771016.USD","IE00BZ1G4Q59.USD","BK4516","LU0795875169.SGD","LU2471134523.USD","IE0004445015.USD","LU2125909247.SGD","LU1066053197.SGD","SG9999015945.SGD","LU2237438978.USD","LU0889565916.HKD","LU2491050071.SGD","LU1929549753.HKD","LU2168564222.USD","LU1814569148.SGD","IE00B7KXQ091.USD","LU0133085943.USD","LU1732799900.SGD","SG9999014914.USD","LU0158827948.USD","IE00BKDWB100.SGD","IE0001KFT4U8.USD","BK4550","LU0353189680.USD","LU1868837300.USD","LU0823434583.USD","LU0683600562.USD","LU0354030511.USD","LU0323591593.USD","LU2468319806.SGD","IE00B2B36J28.USD","LU1221951129.SGD","IE000SO60NU8.SGD","LU0234570918.USD","LU2471134796.USD","LU0353189763.USD","BK4599","LU1145028129.USD","SG9999015952.SGD","IE00BN29S564.USD","LU1291159041.SGD","SG9999001176.USD","LLYZ","BK4559","LU0210536198.USD","LU2264538146.SGD","LU2505996509.AUD","LU0114720955.EUR","LU1551013342.USD","BK4504","LU0061475181.USD","IE00B4JS1V06.HKD","LU1221951046.USD","LU1280957306.USD","LU0053666078.USD","LU2211815571.USD","LU2063271972.USD","LU1066051498.USD","LU0823434740.USD","LU2360106947.USD","BK4568","BK4581","LU2361044865.SGD","LU1974910355.USD","LLYX","BK4534","LU2471134879.HKD","LU1059921491.USD","LU2896262040.SGD","LU2461242641.AUD","LU1043141123.HKD","LU2168564149.EUR","LU1127390331.HKD","LU2430703251.USD","IE00B1BXHZ80.USD","IE00BJJMRZ35.SGD","LU0203347892.USD","LU1119994496.HKD","IE00B42XCP33.USD","SG9999002232.USD","LU0203345920.USD","LU1732800096.USD","LU1917777945.USD","LU0098860793.USD","LU2129689605.HKD","LU1585245621.USD","LU1323610961.USD","LU1069344957.HKD","LU2491050154.USD","LU0158827781.USD","BK4548","LU2168564495.EUR","IE0009355771.USD","LU0456855351.SGD","LU0124676726.USD","LU2129689514.USD","SGXZ99366536.SGD","LU2089283258.USD","LU2065170008.USD","LU1023059063.AUD","LU1629891620.HKD","LU0238689110.USD","LU0203202063.USD","LU2417539215.USD","BK4592","SG9999017495.SGD","LU0471298694.HKD","LU0316494557.USD","BK4082","LU1093756325.SGD","BK4566","LU1093756168.USD","IE00BSNM7G36.USD","LU1712237335.SGD","LU2265009873.SGD","LU0385154629.USD","BK4533","LU1430594728.SGD","LU2361045086.USD","IE00B4R5TH58.HKD","LU0426417589.USD","LU2750360641.GBP","LU1267930813.SGD","LU0345769128.USD","LU2125909593.SGD","LU0417517546.SGD","IE00B19Z3B42.SGD","LU2271345857.HKD","LU2065171402.SGD","IE00BFSS8Q28.SGD","IE00BLSP4239.USD","LU2237443622.USD","LU2106854487.HKD","LU1267930730.SGD","IE00B7SZLL34.SGD","LU1064131342.USD","LU1868836914.USD","LU0432979614.USD","LU2746668974.SGD","ELIS","LU0320765646.SGD","LU2210150020.SGD","LU2462157665.USD","LU2112291526.USD","LU1868837136.USD","LU0882574139.USD","IE00BMPRXR70.SGD","LU0795875086.SGD","IE000M9KFDE8.USD","LU1043141396.HKD","LU2065169927.USD","LU2602419157.SGD","IE00B1XK9C88.USD","LU1162221912.USD","LU1057294990.SGD","LU0109394709.USD","LU0689472784.USD","LU0070217475.USD","LU0786609619.USD","SG9999002224.SGD","SG9999014898.SGD","IE00BKPKM429.USD","LU2129689431.USD","LU2236285917.USD","LU1074936037.SGD","LU2213496289.HKD","LU0345770993.USD","SGXZ31699556.SGD","IE00BKVL7J92.USD","LU0823416689.USD","LU2237443549.SGD","LU0426412945.USD","LU2592432038.USD","IE0002270589.USD","LU1718418525.SGD","LU1720051108.HKD","LU2111349929.HKD","IE00BDGV0183.EUR","LU1121112475.USD","LU2552382215.SGD","LU0256863902.USD","LU1548497426.USD","LU2403377893.USD","LU2023250504.SGD","IE00B3T34201.USD","LU2505996681.GBP","IE00BJLML261.HKD","IE000MB6IJN5.SGD","LU0466842654.USD","LU1032466523.USD","LU0006306889.USD","IE00B775H168.HKD","LU0058720904.USD","LU2552382132.HKD","LU0234572021.USD","LU2552382058.USD","LU1506573853.SGD","IE00BFTCPJ56.SGD","LU1674673691.USD","LU2087625088.SGD","LU0094547139.USD","LU2023250330.USD","SG9999018865.SGD","LU0792757196.USD","LU0471298777.SGD","LU2210149790.SGD","LU2746668461.USD","LU0345769631.USD","IE00BBT3K403.USD","LU0109391861.USD","SG9999001176.SGD","SG9999015978.USD","LU0256863811.USD","LU0079474960.USD","IE00BK4W5L77.USD","LU0889566641.SGD","LU0106261372.USD","LU0640476718.USD","IE000BZT7R73.USD","BK4588","LU2237443465.HKD","LU2491049909.HKD","LU0097036916.USD","LU2430703095.HKD","LU2168563687.JPY","IE00BMPRXN33.USD","LU2133065610.SGD","PODD","LU1228905037.USD","LU1228905540.USD","LU2089284900.SGD","IE00BWXC8680.SGD","LU0787776722.HKD","LU0320765992.SGD","LU2324357040.USD","LU0943347566.SGD","LU2065171311.SGD","LU0689626769.HKD","SG9999018857.SGD","LU2487616109.SGD","IE00BFSS7M15.SGD","LU2237443978.SGD","SG9999013999.USD","IE00BGHQF631.EUR","IE0000B7K699.USD","LU0345770308.USD","LU1894683348.USD","ELIL","LU0820561818.USD","LU0210528500.USD","LU0122379950.USD","LU1244550494.USD","LU1084165304.USD","GB00BDT5M118.USD","LU2168564065.EUR","IE00BVYPNW00.USD","LU0225283273.USD","LU1983299246.USD","LU1868836591.USD","LU1988902786.USD","LU1914381329.SGD","SG9999014906.USD","LU2433249047.HKD","LU0545562505.USD","LU1778281490.HKD","LU2750360997.AUD","LU2347655156.SGD","SG9999015986.USD","SGXZ51526630.SGD","IE0002141913.USD","IE00B3PB1722.GBP","LU0672654240.SGD","IE00BJJMRY28.SGD","IE00BK4W5M84.HKD","LLII","IE0004445239.USD","IE00B19Z3581.USD","LU2361044949.HKD","LU2023251221.USD","LU0096364046.USD","SGXZ81514606.USD","LU0882574055.USD","BK4532","LU2028103732.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0009},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.0817},{"period":"6month","weight":0.1147},{"period":"1year","weight":0.2431},{"period":"ytd","weight":0.0832}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4007","nameEN":"BK4007"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharmacy,BK4007,Pharmacy股票,Pharmacy股票老虎,Pharmacy股票老虎国际,Pharmacy行情,Pharmacy股票行情,Pharmacy股价,Pharmacy股市,Pharmacy股票价格,Pharmacy股票交易,Pharmacy股票购买,Pharmacy股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction